Skip to main content
Top

Clinical & Experimental Metastasis

Issue 5/2012

Content (9 Articles)

Research Paper

Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization

Russell O. Bainer, Jennifer Taylor Veneris, S. Diane Yamada, Anthony Montag, Mark W. Lingen, Yoav Gilad, Carrie W. Rinker-Schaeffer

Research Paper

Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2

Obul R. Bandapalli, Stephan Macher-Goeppinger, Peter Schirmacher, Karsten Brand

Research Paper

The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread

Elizabeth Rapa, Sophie K. Hill, Karl J. Morten, Michelle Potter, Chris Mitchell

Research Paper

Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model

Thangirala Sudha, Patricia Phillips, Camille Kanaan, Robert J. Linhardt, Lubor Borsig, Shaker A. Mousa

Research Paper

Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions

Christina Reufsteck, Rinat Lifshitz-Shovali, Michael Zepp, Tobias Bäuerle, Dieter Kübler, Gershon Golomb, Martin R. Berger

Research Paper

Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways

Suboj Babykutty, Priya Suboj, Priya Srinivas, Asha S. Nair, K. Chandramohan, Srinivas Gopala

Research Paper

Luminal breast cancer metastasis is dependent on estrogen signaling

Vidya Ganapathy, Whitney Banach-Petrosky, Wen Xie, Aparna Kareddula, Hilde Nienhuis, Gregory Miles, Michael Reiss

Research Paper

Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA

Simon Toupance, Bertrand Brassart, Fanja Rabenoelina, Christelle Ghoneim, Laurent Vallar, Myriam Polette, Laurent Debelle, Philippe Birembaut

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine